Yong Shen Fang
Direktor/Vorstandsmitglied bei Sino European Biotechnology AG
Ursprung des Netzwerks ersten Grades von Yong Shen Fang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Sino European Biotechnology AG
 Sino European Biotechnology AG Medical SpecialtiesHealth Technology Sino European Biotechnology AG develops virus vaccines. Its products include Insulidow capsules to treat diabetes, Prostaidin for prostate disease-specific, Osteogird for bone diseases, Keanbo, the anti-tumour and immune capsules and RYR capsules to treat cholesterol, triglycerides and blood viscosity lipids. The company is headquartered in Zurich, Switzerland.
4
| Private Company | Medical Specialties | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yong Shen Fang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| The Chinese Medical Association | Corporate Officer/Principal | ||
Zhejiang Chinagene Biomedical Co. Ltd.
 Zhejiang Chinagene Biomedical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino European Biotechnology AG, Zhejiang Chinagene Biomedical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Hangzhou, China. Zhejiang Chinagene Biomedical Co. was acquired by Sino European Biotechnology AG on March 31, 2010. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| China | 3 |
Sektoral
| Health Technology | 2 |
Operativ
| Director/Board Member | 4 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Zi Hao Liang | 2 |
| Yao Zhou Zhang | 2 |
| Yi Zhong David Qi | 1 |
| Li Ping Tang | 1 |
- Börse
- Insiders
- Yong Shen Fang
- Unternehmensverbindungen
